VFA
SAGE
Values First Advisors’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $203K | Buy |
22,296
+412
| +2% | +$3.76K | 0.11% | 160 |
|
|
2025
Q1 | $175K | Buy |
21,884
+635
| +3% | +$5.07K | 0.1% | 162 |
|
|
2024
Q4 | $115K | Sell |
21,249
-6,698
| -24% | -$36.4K | 0.06% | 187 |
|
|
2024
Q3 | $202K | Sell |
27,947
-1,015
| -4% | -$7.33K | 0.11% | 148 |
|
|
2024
Q2 | $315K | Buy |
28,962
+11,086
| +62% | +$120K | 0.19% | 120 |
|
|
2024
Q1 | $335K | Buy |
17,876
+896
| +5% | +$16.8K | 0.2% | 125 |
|
|
2023
Q4 | $368K | Buy |
16,980
+6,354
| +60% | +$138K | 0.22% | 121 |
|
|
2023
Q3 | $219K | Buy |
+10,626
| New | +$219K | 0.14% | 136 |
|
|
2023
Q2 | – | Sell |
-1
| Closed | -$40 | – | 329 |
|
|
2023
Q1 | $40 | Buy |
+1
| New | +$40 | ﹤0.01% | 354 |
|
|
2020
Q2 | – | Sell |
-11,563
| Closed | -$332K | – | 142 |
|
|
2020
Q1 | $332K | Buy |
11,563
+7,320
| +173% | +$210K | 0.4% | 75 |
|
|
2019
Q4 | $306K | Buy |
+4,243
| New | +$306K | 0.3% | 100 |
|